openPR Logo
Press release

Emerging Opportunities in RSV Diagnostics Market with Current Trends Analysis (2013-2019)

12-11-2017 08:41 AM CET | Health & Medicine

Press release from: Transparency Market Research

Emerging Opportunities in RSV Diagnostics Market with Current

Human respiratory syncytial virus (RSV) is a virus that commonly causes lower respiratory tract infection. Human respiratory syncytial virus infections are acquired during hospital visits. Infants and in young children are more prone to human respiratory syncytial virus (RSV) infection. RSV infections affect lungs and respiratory tract of an individual. In premature babies and children with previous presence of diseases, RSV infections affect heart and immune systems as well resulting in serious illness. Common symptoms of RSV infection include, cold, cough, headache and weakness. Human RSV infection is highly contagious and its mode of transfer is through liquid droplets produced during coughing and sneezing.

Report Overview and TOC @ https://www.transparencymarketresearch.com/rsv-diagnostics-market.html

All the RSV diagnostics tests currently available in the market use sputum and saliva as specimen for detection of RSV infection. Based on the tests used to detect RSV
infection, this market is segmented as follows:

Immunofluorescence
Rapid antigen detection test
Cell culture test
Reverse transcriptase polymerase chain reaction (RT-PCR) kits
Serological tests
Others

Request for Broucher @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2080

Many clinics perform antigen detection test for diagnosis of human respiratory syncytial virus infection. In most of the cases, results of antigen detection tests are validated by cell culture tests. Antigen detection testsare 80% to 90% more sensitive than cell culture test for detection of RSV infection. Currently, reverse transcriptase polymerase chain reaction (RT-PCR) kits are also available in the market for the detection of human respiratory syncytial virus. Though serological tests are available in the market, they are less frequently used for routine diagnosis. Furthermore,based on the type of end users, the RSV diagnosis market is segmented as follows:

Hospitals
Physicians’ offices
Commercial labs
Private Labs
Some of the major companies contributing to global RSV diagnostics market are Becton, Dickinson and Company, Abbott Laboratories, Alere, Inc., Quidel Corporation, and Focus Diagnostics, Inc.

Pre Book Full Report @ https://www.transparencymarketresearch.com/rsv-diagnostics-market.html?secure=NTIxNS41&type=PB

ABOUT US:
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

CONTACT:
Transparency Market Research
State Tower
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-345

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Emerging Opportunities in RSV Diagnostics Market with Current Trends Analysis (2013-2019) here

News-ID: 853699 • Views:

More Releases from Transparency Market Research

Transformer Dismantling & Recycling Services Market Outlook 2034: How Sustainable Disposal, Circular Materials Recovery, and Grid Modernization Are Driving Global Transformer End-of-Life Management
Transformer Dismantling & Recycling Services Market Outlook 2034: How Sustainabl …
As global energy systems evolve and electricity demand rises, the safe, efficient, and environmentally responsible disposal of aging electrical infrastructure has become an urgent priority. Transformers-critical components of transmission and distribution networks-must be replaced or refurbished regularly due to wear, efficiency loss, safety concerns, or regulatory mandates. Transformer dismantling and recycling services play a vital role in ensuring that these large, complex electrical units are decommissioned safely while valuable materials
Online Dating Services Market Outlook 2034: How Digital Matchmaking Platforms Are Redefining Relationship Building, User Engagement, and Revenue Growth in a Hyperconnected World
Online Dating Services Market Outlook 2034: How Digital Matchmaking Platforms Ar …
The online dating services market has undergone a remarkable transformation over the past decade, evolving from simple matchmaking websites to highly intelligent, data-driven platforms that use artificial intelligence, behavioral insights, and preference-based algorithms to match users more effectively. The rise of mobile apps, digital socialization, and increased acceptance of online dating across age groups has made digital matchmaking a mainstream phenomenon. In 2023, the global online dating services market was
Ambulatory Infusion Centers Market Outlook 2035: Transforming Outpatient Care Through Efficiency, Affordability, and Advanced Therapies
Ambulatory Infusion Centers Market Outlook 2035: Transforming Outpatient Care Th …
Ambulatory infusion centers (AICs) have become one of the most rapidly expanding components of modern healthcare, driven by a growing emphasis on outpatient care solutions, the rising prevalence of chronic diseases, and increasing adoption of advanced biologics. These specialized centers provide infusion therapies outside of hospital settings, offering patients convenience, affordability, and improved treatment experiences. As healthcare systems worldwide shift toward models that prioritize cost savings, patient comfort, and efficient
Amyloidosis Therapeutics Market Outlook 2035: Advancements in Rare Disease Treatment to Drive Market Beyond US$ 6.3 Bn
Amyloidosis Therapeutics Market Outlook 2035: Advancements in Rare Disease Treat …
The global healthcare landscape is witnessing a growing focus on rare diseases, propelled by increasing awareness, expanded diagnostic capabilities, and advancements in personalized medicine. Amyloidosis, a group of rare but severe conditions caused by the buildup of abnormal amyloid proteins in tissues and organs, has moved into the spotlight as medical science uncovers more effective treatments and diagnostic tools. The amyloidosis therapeutics market, valued at US$ 2.7 billion in 2024,

All 5 Releases


More Releases for RSV

The Rise In The Prevalence Of RSV Infection : A Key Catalyst Accelerating Global …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Respiratory Syncytial Virus (RSV) Therapeutics Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market encompassing therapeutics for respiratory syncytial virus (rsv) has witnessed substantial, rapid expansion lately, projected to increase its valuation from $1.6 billion in 2024 to $2 billion just one year later
The Rise In The Prevalence Of RSV Infection : Transformative Forces Shaping the …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Respiratory Syncytial Virus (RSV) Therapeutics Industry Market Size Be by 2025? The market size for therapeutics treating the respiratory syncytial virus (RSV) has seen significant expansion in the past few years. It is expected to surge from $1.6 billion in 2024 to $2 billion in 2025,
RSV Vaccine Market To Reach 731 million by 2040, Due To Increasing Awareness on …
According to our latest market report "RSV Vaccine Market, Till 2040 by Type of Vaccine, Route of Administration, Target Patient Population, Distribution Channel, Key Geographical Regions and Leading Players", the RSV Vaccine market size is projected to reach USD 731 million by 2040 from USD 1,149 million in current year, during the forecast period. To request quote of this report, please visit: https://www.rootsanalysis.com/reports/rsv-vaccine-market/request-quote.html In the dynamic landscape of preventive therapies for respiratory
Global RSV Diagnostic Products Market Size & Trends
According to a new market research report published by Global Market Estimates, the global RSV diagnostic products market is expected to grow at a CAGR of 11.4% from 2023 to 2028. Ongoing advancements in diagnostic technologies, specifically PCR and rapid point-of-care testing, play a crucial role. These advancements offer heightened accuracy, faster results, and increased accessibility, enabling prompt and precise identification of RSV infections. Browse 147 Market Data Tables and 115 Figures
Respiratory Syncytial Virus (RSV) Therapeutics Market Size to Reach USD 9080.84 …
Respiratory Syncytial Virus (RSV) Therapeutics Market Scope & Overview Respiratory Syncytial Virus (RSV) Therapeutics Market size was USD 1040.65 Million in 2022 and is expected to Reach USD 9080.84 Million by 2030 and grow at a CAGR of 31.1% over the forecast period of 2023-2030. The Respiratory Syncytial Virus (RSV) Therapeutics market is a vibrant, fiercely competitive sector that is essential to digital marketing. The demand for effective has increased as companies
Respiratory Syncytial Virus (RSV) Therapeutics Market - Conquering RSV: Advancin …
Newark, New Castle, USA: The "Respiratory Syncytial Virus (RSV) Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Respiratory Syncytial Virus (RSV) Therapeutics Market: https://www.growthplusreports.com/report/respiratory-syncytial-virus-rsv-therapeutics-market/8519 This latest report